Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

22 Apr 2014 15:00

RNS Number : 2466F
Maven Income and Growth VCT 5 PLC
22 April 2014
 

Maven Income and Growth VCT 5 PLC (the Company)

 

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at 10.00 am in Kintyre House, 205 West George Street,Glasgow G2 2LW on 22 April 2014, all of the Resolutions put to the Meeting were duly passed.

 

At the record date for the Annual General Meeting, being 16 April 2014, the total number of voting rights in the Company stood at 67,512,435 and the total shares in issue were 67,512,435. In accordance with the provisions of D.2.2 of the Combined Code on Corporate Governance, the Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 9,973,024 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Annual Report and audited Financial Statements

9,698,626

225,840

3,000

45,558

9,973,024

2

To approve the Directors' Remuneration Report

9,281,310

223,895

257,886

209,933

9,973,024

3

To approve the Directors' remuneration policy

9,116,339

223,895

377,440

255,350

9,973,024

4

To approve a final dividend

9,727,398

218,732

6,894

20,000

9,973,024

5

To re-elect Mr G Humphries as a Director

9,501,875

230,892

155,035

85,222

9,973,024

6

To re-elect Mr A Langlands as a Director

9,528,356

230,892

131,445

82,331

9,973,024

7

To re-elect Mr C Young as a Director

9,529,981

230,892

126,929

85,222

9,973,024

8

To appoint KPMG LLP as Auditor

 

9,365,053

232,251

139,385

236,335

9,973,024

9

To authorise the Directors to fix the remuneration of the Auditor

8,857,375

869,099

155,211

91,339

9,973,024

10

To authorise the Directors to allot new shares

9,372,867

232,251

38,299

329,607

9,973,024

11

To authorise disapplication of pre-emption rights

9,024,099

235,912

343,050

369,963

9,973,024

12

To authorise the Company to purchase its own shares

9,081,703

227,088

507,125

157,108

9,973,024

13

To allow a General Meeting to be called on not less than 14 days' notice

9,295,230

232,251

296,268

149,275

9,973,024

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. The voting figures will be available to view at: www.mavencp.com/migvct5.

 

Passing of Resolutions under Special Business

 

The Special Resolutions have been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.//hemscott.com/nsm.do.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

22 April 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGITMITMBMTBMI
Date   Source Headline
3rd May 20249:28 amRNSIssue of Equity
1st May 202410:10 amRNSIssue of Equity
26th Apr 20242:44 pmRNSUnaudited NAV - Dividend Investment Scheme
23rd Apr 20242:27 pmRNSResult of AGM
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:49 pmRNSIssue of Equity
27th Mar 202410:31 amRNSIssue of Equity
22nd Mar 20244:25 pmRNSStatement re Offer for Subscription
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:48 pmRNSUnaudited Net Asset Value
8th Mar 20242:57 pmRNSAnnual Financial Report
15th Feb 20244:45 pmRNSTransaction in Own Shares
8th Feb 202410:33 amRNSDirector/PDMR Shareholding
8th Feb 202410:12 amRNSIssue of Equity
7th Feb 20243:09 pmRNSDividend Declaration
19th Dec 20233:28 pmRNSIssue of Equity
18th Dec 20235:24 pmRNSUnaudited Net Asset Value
9th Nov 20233:51 pmRNSResult of General Meeting
20th Oct 20234:13 pmRNSTransaction in Own Shares
13th Oct 20234:56 pmRNSPublication of a Prospectus
4th Oct 20234:03 pmRNSNet Asset Value(s)
29th Aug 20239:15 amRNSDirectorate Change
24th Jul 202311:16 amRNSHalf-year Report
21st Jul 20234:43 pmRNSTransaction in Own Shares
21st Jul 20239:48 amRNSIssue of Equity
17th Jul 202310:57 amRNSNet Asset Value - Dividend Investment Scheme
11th Jul 20234:47 pmRNSNet Asset Value
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
14th Jun 202310:33 amRNSDividend Declaration
2nd Jun 20239:48 amRNSIssue of Equity
5th May 202310:23 amRNSIssue of Equity - Dividend Investment Scheme
27th Apr 20233:57 pmRNSTransaction in Own Shares
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202311:39 amRNSNet Asset Value - Dividend Investment Scheme
25th Apr 20233:14 pmRNSNet Asset Value(s)
25th Apr 202312:50 pmRNSResult of AGM
5th Apr 202312:32 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
23rd Mar 20235:18 pmRNSAnnual Financial Report
3rd Mar 20239:56 amRNSIssue of Equity
21st Feb 20234:44 pmRNSTransaction in Own Shares
8th Feb 202310:24 amRNSDirector/PDMR Shareholding
8th Feb 20239:48 amRNSIssue of Equity
1st Feb 20233:25 pmRNSUnaudited NAV and Proposed Final Dividend
9th Nov 20223:02 pmRNSResult of General Meeting
4th Nov 20223:25 pmRNSTransaction in Own Shares
26th Oct 20223:53 pmRNSTransaction in Own Shares
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
4th Oct 20221:35 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.